Zunyan Dai

WinnMed — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index4.0kcitations75works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(23), RNA modifications and cancer(18), MicroRNA in disease regulation(10), Drug Transport and Resistance Mechanisms(9), Cancer-related gene regulation(8)

Publications75 total

Leveraging large language models (LLM) to guide adjuvant chemotherapy (AC) recommendations in stage III colorectal cancer (CRC).
Journal of Clinical Oncology·2026
Integrated EVLP and single-cell profiling uncovers aberrant activation of tissue-resident lymphocytes and pro-fibrotic GZMK⁺ CD8 T cells in IPF
2025Open Access
A Machine Learning-Based Privacy-Preserving Medical Diagnostic System
Advances in transdisciplinary engineering·2025Open Access
Experience of sexual relationship of patients after radical prostatectomy: a qualitative study
Frontiers in Psychology·2025· 1 citedOpen Access
Data from MicroRNAs modulate the chemosensitivity of tumor cells
2023Open Access
Data from MicroRNA expression profiles for the NCI-60 cancer cell panel
2023Open Access
Supplementary Fig. S1 from MicroRNA expression profiles for the NCI-60 cancer cell panel
2023Open Access
Data from MicroRNA expression profiles for the NCI-60 cancer cell panel
2023Open Access
Data from MicroRNAs modulate the chemosensitivity of tumor cells
2023Open Access
Supplementary Fig. S1 from MicroRNA expression profiles for the NCI-60 cancer cell panel
2023Open Access
Supplementary Data from MicroRNAs modulate the chemosensitivity of tumor cells
2023Open Access
Supplementary Data from MicroRNAs modulate the chemosensitivity of tumor cells
2023Open Access
Supplementary Data from Membrane Transporters and Channels
2023Open Access
Data from Membrane Transporters and Channels
2023Open Access
Supplementary Data from Membrane Transporters and Channels
2023Open Access
Data from Membrane Transporters and Channels
2023Open Access
A Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas
UNC Libraries·2020Open Access
36. Quadruple-hit B-cell lymphoma with simultaneous BCL2, BCL6, CCND1, and MYC rearrangements: Two new cases
Cancer Genetics·2020· 2 cited
[Standards and regulations for reporting clinical genetic testing results in the United States].
PubMed·2019· 1 cited
Caution in interpretation of disease causality for heterozygous loss-of-function variants in the MYH8 gene associated with autosomal dominant disorder
European Journal of Medical Genetics·2017· 7 cited
page 1 of 4Next →

Frequent Co-authors

Wolfgang Sadée(22), Christoph Plass(15), Ying Huang(11), Paul E. Blower(7), Audrey C. Papp(6), Gregory A. Otterson(6), Michael C. Frühwald(6), Dominic J. Smiraglia(6), Cátálin Bárbácioru(5), Wei‐Guo Zhu(5), M. Sue O’Dorisio(5), Laura J. Rush(5), William C. Reinhold(4), John N. Weinstein(4), Miguel A. Villalona‐Calero(4), Wenrui Duan(3), Michael R. Grever(3), Fred A. Wright(3), Jim Xiao(3), John C. Byrd(3)